ECG | Pharmaphorum

Skip to main content

Wednesday 8 February 2023

twitter linkedin facebook rss

User account menu

Sign in
Sign up

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

ECG

News

Card image cap

NICE backs AliveCor's smartphone-linked ECG for NHS use

In draft guidance, NICE has said that AliveCor's ECG recording device should be an option to check or heart disturbances in patients who take antipsychotic medicines.

Digital

Card image cap

Are Apple’s healthcare ambitions too broad?

Apple pledged to make a giant impact in the healthcare industry, but Susan Lang, founder and CEO of XIL Health, says its focus on changing healthcare as a whole is an issue.

News

Card image cap

AliveCor launches six-lead ECG smartphone device in UK

AliveCor has announced the launch of its flagship KardiaMobile six-lead personal ECG smartphone device in the UK.

News

Card image cap

Alphabet's smart watch ECG gets FDA backing

Alphabet’s life science subsidiary Verily is the latest firm to get an electrocardiogram (ECG) watch approved by the FDA.

Editor’s Picks

Welcome to the new pharmaphorum
Roche names Teresa Graham as its new pharma chief
How can digital and AI optimise the delivery of support?
How Moderna kept diversity in mind amid vaccine development
JP Morgan 2023 – Alexandre LeVert

News

Card image cap

Aldeyra’s reproxalap for dry eye disease accepted by FDA

Biotech Aldeyra Therapeutics has announced that the US Food and Drug Administration (FDA) has accepted its New D

News

Card image cap

Welcome to the new pharmaphorum

Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on
- Frontiers Health 2022
- The Future of Generics

Sign up for email newsletters and Deep Dive

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2023, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company